Bullying People With Hidden Disabilities Creates Misery, Fear

Bullying of disabled people is extensive. According to a Columbia University study, 1 in 3 disabled children have globally experienced violence. It is not only children who are the target of bullying; bias against disabled adults is also common. In my almost 30 years of treating people with disabilities, I have seen the intense emotional … Read more

Novel Long-Acting Injection Cuts Schizophrenia Relapse

A long-acting subcutaneous antipsychotic (LASCA) suspension that combines risperidone with a novel copolymer substantially reduces both risk for relapse and time to impending relapse for patients with schizophrenia, new research suggests. In the phase 3 Risperidone Subcutaneous Extended-release (RISE) trial, which included more than 500 patients with schizophrenia, those who received the novel combination treatment, … Read more

Juvenile Fibromyalgia Is Associated With Brain Changes

Juvenile fibromyalgia is associated with reduced volume in one region of the brain, according to a recent study. The findings were similar to those in patients with adult fibromyalgia, which suggest the importance of early diagnosis and treatment. The study was published online January 25 in Arthritis and Rheumatology. Adolescent Brain Development Juvenile fibromyalgia is … Read more

Women Have Made Strides in Medicine, but There Are Miles to Go

As a female physician, I was excited that March was recognized as International Women’s Month. Reflecting back on the day, I was happy about the strides the medical community has made in regards to including women and treating women as equals. As the only woman in my residency class, it is clear that the medical … Read more

From COVID to Ukraine, Fighting Crisis Fatigue

In casual conversation these days, you’re likely to hear: “I’m just done with COVID.” The problem is the virus isn’t done with us, yet. Nor is Ukraine inflation, or nuclear threats, to name a few. The statistics 2 years into the pandemic are sobering, or should be. Deaths from COVID-19 in the United States are … Read more

Placebo Response in Neuropathic Pain Trials

The study covered in this summary was published in medRxiv.org as a preprint and has not yet been peer reviewed. Key Takeaways Both placebo and nocebo effects can greatly affect the interpretation of outcomes in randomized controlled trials of chronic neuropathic pain treatments. When trials are being designed and interpreted, these effects need to be … Read more